ArticleBMC musculoskeletal disorders2024
Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea.
Seungju Cha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it